Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: Comparison with multidetector-row CT

British Journal of Radiology

Volumn 85, Issue 1013, 2012, Pages 539-547

  Kim, Young Kon ^a,b   Park, G ^a   Kim, C S ^a   Yu, H C ^a   Han, Y M ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID; IOPROMIDE;

ADULT; AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CYST; LIVER HEMANGIOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ADULT; AGED; CONTRAST MEDIA; CYSTS; FEMALE; GADOLINIUM DTPA; HEMANGIOMA; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84860910991     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/25139667     Document Type: Article

References (29)

1. Fusai G, Davidson BR. Management of colorectal liver metastases. Colorectal Dis 2003;5:2-23. (Pubitemid 36367460)
2. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 2003;97:3027-35. (Pubitemid 36676257)
3. Evrard S, Becouarn Y, Fonck M, Brunet R, Mathoulin-Pelissier S, Picot V. Surgical treatment of liver metastases by radiofrequency ablation, resection, or in combination. Eur J Surg Oncol 2004;30:399-406. (Pubitemid 38528924)
4. Hawksworth J, Geisinger K, Zagoria R, Kavanagh P, Howerton R, Levine EA, et al. Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor. Am Surg 2004;70:512-17.
5. Jones EC, Chezmar JL, Nelson RC, Bernardino ME. The frequency and significance of small hepatic lesions (<15 mm) detected by CT. AJR Am J Roentgenol 1992;158:535-9.
6. Haider MA, Amitai MM, Rappaport DC, O'Malley ME, Hanbidge AE, Redston M, et al. Multi-detector row helical CT in preoperative assessment of small (≤1.5 cm) liver metastases: is thinner collimation better? Radiology 2002; 225:137-42.
7. Krakora GA, Coakley FV, Williams G, Yeh BM, Breiman RS, Qayyum A. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer. Radiology 2004;233:667-73.
8. Hagspiel KD, Neidel KFW, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron-oxide-enhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995;196:471-8.
9. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative free response receiver operating characteristic analysis. Radiology 1999;210:459-66. (Pubitemid 29055316)
10. 1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences. J Magn Reson Imaging 1994;4:319-23.
11. Bartolozzi C, Donati F, Cioni D, Procacci C, Morana G, Chiesa A, et al. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 2004;14:14-20. (Pubitemid 38181050)
12. Kim KW, Kim AY, Kim TK, Park SH, Kim HJ, Lee YK, et al. Small (≤2 cm) hepatic lesions in colorectal cancer patients: detection and characterization on mangafodipir trisodium-enhanced MRI. AJR Am J Roentgenol 2004;182:1233-40. (Pubitemid 38525520)
13. Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 2006;16:1337-45. (Pubitemid 43834721)
14. Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 1997;7:275-80. (Pubitemid 127538595)
15. Kim YK, Lee YH, Kwak HS, Kim CS, Han YM. Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran- enhanced MR imaging. Eur J Radiol 2010;73:131-6.
16. Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin ME, Blomgvist L, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodiumenhanced MRI and biphasic CT - a multicenter trial. J Comput Assist Tomogr 2006;30:345-54. (Pubitemid 43922248)
17. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT- initial observations. Radiology 2005;234:468-78. (Pubitemid 40139918)
18. Huppertz A, Balzer T, Blakeborough, Breuer J, Giovagnoni A, Heinz-Peer G, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230:266-75. (Pubitemid 37549812)
19. Park G, Kim YK, Kim CS, Yu HC, Hwang SB. Diagnostic efficacy of gadoxetic acid-enhanced MR imaging in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine. Br J Radiol 2010; 83:1010-16.
20. Chakraborty DP, Winter LH. Free-response methodology: alternate analysis and a new observer-performance experiment. Radiology 1990;74:873-81. (Pubitemid 20089690)
21. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986;21:720-33. (Pubitemid 16015664)
22. Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992;48:577-85.
23. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. (Pubitemid 8054849)
24. Kim YK, Kwak HS, Kim CS, Han YM. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxetic acid. J Magn Reson Imaging 2009;30:437-43.
25. Brody JM, Schafer L, Tung GA, Breuer J, Shamsi K. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. J Magn Reson Imaging 2005;21:391-7. (Pubitemid 40446434)
26. Carpenter KD, Macaulay SE, Schulte SJ, Obregon RG, Nelson RC, Simon HE, et al. MR of focal liver lesions: comparison of breath-hold and non-breath-hold hybrid RARE and conventional spin-echo T2-weighted pulse sequences. J Magn Reson Imaging 1996;6:596-602. (Pubitemid 126701430)
27. Kanematsu M, Hoshi H, Murakami T, Itoh K, Hori M, Inaba Y, et al. Fat-suppressed T2-weighted MR imaging of hepatocellular carcinoma and metastases: comparison of conventional spin-echo, fast spin-echo, and echoplanar pulse sequences. J Magn Reson Imaging 1999;10:25-32. (Pubitemid 29336635)
28. Gabata T, Matusi O, Kadoya M, Yoshikawa J, Ueda K, Kawamori Y, et al. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 1998;23:309-13. (Pubitemid 28213309)
29. Kim YK, Lee JM, Kim CS. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 2004;14:5-13. (Pubitemid 38181049)